✦ LIBER ✦

PHV11: COST-MINIMIZATION ANALYSIS OF AZITHROMYCIN IV/PO VERSUS CEFUROXIME IV/PO ± ERYTHROMYCIN IV/PO FOR COMMUNITY-ACQUIRED PNEUMONIA

✍ Scribed by AH Wong; E Phillips; SAN Tailor; W Cornish; NH Shear; F Lavoie

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of sequential IV/PO

✍ H Lode,S Choudhri,D Haverstock,P Jackson,D Church 📂 Article 📅 2002 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 1021 KB

AR3 MOXIFLOXACIN IV/PO MONOTHERAPY IS CO

✍ M Drummond; D Becker; M Hux; J Chancellor; I Duprat-Lomon; PP Sagnier 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PIN10 ECONOMIC EVALUATION DEMONSTRATES T

✍ M Drummond; D Becker; M Hux; J Chancellor; I Duprat-Lomon; PP Sagnier 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Evaluation of an algorithm for switching

✍ Menno M. Van der Eerden; Casper S. de Graaff; Fer Vlaspolder; Willem Bronsveld; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 106 KB